These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8610280)

  • 41. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
    Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
    Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer.
    Nakano K; Sugiyama K; Satoh H; Arifuku H; Fujimatsu T; Yoshida N; Watanabe H; Tokita S; Wakayama T; Tatewaki M; Souma R; Masuda H; Koyama K; Hirata H; Fukushima Y
    Intern Med; 2017; 56(14):1799-1806. PubMed ID: 28717074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
    Hong SK; Kim JE; Han KS; Kim HK
    Thromb Res; 2013 Sep; 132(3):392-7. PubMed ID: 23954259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical usefulness of plasma interleukin-6 and interleukin-10 in disseminated intravascular coagulation].
    Seo JW; Kim HK; Lee DS; Cho HI
    Korean J Lab Med; 2007 Apr; 27(2):83-8. PubMed ID: 18094556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
    Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
    Shock; 2015 May; 43(5):443-9. PubMed ID: 25608138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
    Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
    Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
    Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
    Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
    Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
    Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Level of Thrombomodulin is Associated with Endothelial Injury in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Tao J; Guo X; Li D; Li Y
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
    Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
    Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.
    Eguchi Y; Gando S; Ishikura H; Saitoh D; Mimuro J; Takahashi H; Kitajima I; Tsuji H; Matsushita T; Tsujita R; Nagao O; Sakata Y
    J Intensive Care; 2014; 2(1):30. PubMed ID: 25520842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.
    Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Kitamura N; Saitoh D
    Crit Care; 2016 Sep; 20():287. PubMed ID: 27629997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation.
    Shirahata A; Mimuro J; Takahashi H; Tsuji H; Kitajima I; Matsushita T; Eguchi Y; Kitamura N; Honda G; Sakata Y
    Clin Appl Thromb Hemost; 2014 Jul; 20(5):465-72. PubMed ID: 24563247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
    Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
    Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
    Inoue Y; Matsunawa M; Sano F; Miura I
    Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines.
    Walborn A; Hoppensteadt D; Syed D; Mosier M; Fareed J
    Clin Appl Thromb Hemost; 2018 May; 24(4):625-632. PubMed ID: 28514870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation.
    Murata A; Okamoto K; Mayumi T; Muramatsu K; Matsuda S
    Int J Clin Pharm; 2015 Feb; 37(1):139-47. PubMed ID: 25515615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.